Novartis India Limited (BOM:500672)
India · Delayed Price · Currency is INR 1,961.40
-9.15 (-0.46%)
At close: Sep 25, 2026
Novartis India Market Cap
Novartis India has a market cap or net worth of 48.43 billion as of September 25, 2026. Its market cap has increased by 119.86% in one year.
Market Cap
48.43B
Enterprise Value
41.78B
Revenue
3.71B
Ranking
n/a
PE Ratio
49.53
Stock Price
1,961.40
ChartMarket Cap Chart
Since April 14, 1999, Novartis India's market cap has increased from 12.59B to 48.43B, an increase of 284.80%. That is a compound annual growth rate of 5.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 48.43B | 151.78% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Procter & Gamble Health | 89.87B |
| Bliss GVS Pharma | 75.38B |
| Sanofi India | 72.31B |
| Morepen Laboratories | 66.00B |
| FDC Limited | 55.53B |
| Gufic Biosciences | 42.41B |
| Unichem Laboratories | 38.74B |
| Kwality Pharmaceuticals | 38.10B |